secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nexalin Technology, Inc. (NXL)
CIK:        0001527352
Form:       8-K/A
Filed at:   2022-09-20T23:59:59+00:00
Accession:  0001829126-22-017024
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nexalin Technology closes $9.6M IPO; shares and warrants begin trading on Nasdaq
--------------------------------------------------------------------------------

- Closed IPO of 2,315,000 units at $4.15/unit (1 share + 1 warrant); gross proceeds $9.6M, net $8.7M.
- Warrants exercisable at $4.15 for 3 years (until Sept 19, 2025); redeemable at $0.01 if stock >$12.45 for 20 of 30 days.
- Maxim Group partially exercised overallotment, purchasing 347,250 warrants.
- Gen-2 neurostimulation device approved in China by NMPA for insomnia and depression.
- Shares (NXL) and warrants (NXLIW) began trading on Nasdaq on Sept 16, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527352/000182912622017024/0001829126-22-017024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527352/000182912622017024/nexalintech_8ka1.htm
  HTML page:      https://secwatch.observer/filing/0001829126-22-017024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer